Synchron

Raised $200M in a Series D round, announced 6 November 2025.

Total raised
$200M

Latest round Series DCountry United StatesSector Health

Round

$200MSeries D, 6 November 2025

Series D funds pivotal trials, commercial launch preparation and hiring.

Amount
$200M
Stage
Series D
Announced
6 November 2025
Lead
Double Point Ventures
Other investors
National Reconstruction Fund, T.Rx Capital, Qatar Investment Authority, K5 Global, Protocol Labs, IQT
Use of funds
Series D funds pivotal trials, commercial launch preparation and hiring.
Checked
Announced by the company
Sources
Synchron Raises $200 Million Series D to Advance Brain-Computer Interface Technology - Business Wire iconnect007.com
Synchron Raises $200 Million Series D to Advance Brain-Computer Interface Technology - Business Wire Business Wire
Synchron Raises $200 Million Series D to Advance Brain-Computer Interface Technology - Business Wire news.crunchbase.com
Newsletter Startup rounds, in your inbox.

Free. Unsubscribe anytime.

Company

Stentrode brain-computer interface implanted without open brain surgery

Based in
New York, United States
Sector
Health
Website
synchron.com ↗

Links

Website
synchron.com ↗

Questions

How much has Synchron raised?

Synchron raised $200M in a Series D round, announced on 6 November 2025.

Who invested in Synchron?

Double Point Ventures led. Investors include Double Point Ventures, National Reconstruction Fund, T.Rx Capital, Qatar Investment Authority, K5 Global and Protocol Labs.